Jim was diagnosedwith multiple myeloma in early 2014. His diagnosis came after he noticed a slowed pace while cycling and not feeling like that was quite normal. Being an avid cyclist his whole life, Jim jumped into treatment and focused on getting better and getting back into riding shape. Jim rode the first two weeks of the cross-countryride in 2017, and is happy to be back on the Road to Victories team as he continues to push forwards in life, and in cycling.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.About Janssen Oncology
Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.Learn More